Abstract: An explosion venting plate and an energy storage cabinet are disclosed. The explosion venting plate includes a plate body, a thermal insulation member, a gasket and a first seal. The plate body has a slit, and the plate body has a first side and a second side opposite to each other in a thickness direction. The thermal insulation member is arranged on the first side. The gasket is arranged on the second side, and is arranged around a periphery of the plate body and configured to seal the slit on the second side. The first seal is arranged on the first side and configured to seal the slit on the first side. Therefore, the sealing performance of the explosion venting plate is improved and the sealing of the explosion venting plate are relatively stable and reliable.

Abstract: The present invention relates to a new bio-based methyl dihydrojasmonate and cyclopentanone. Methyl dihydrojasmonate having a bio-based carbon content greater than or equal to 30% and/or a number of carbon atoms from bio-based origin greater than or equal to 2, and cyclopentanone having a bio-based carbon content higher or equal to 50% or a number of carbon atoms from bio-based origin greater than or equal to 2 are described. The invention further relates to a process for their preparations and the use of such compounds.

Abstract: The present invention therefore pertains to a process for desulfurizing a sulfur compound-containing liquid fossil fuel. By continuously adding a solution comprising an oxidant to the sulfur compound-containing liquid fossil fuel, it is possible to improve oxidant utilization and achieve higher sulfur removal rate.

Abstract: The invention relates to a new method for producing twin-tail triamines, preferably fatty twin-tail triamines Furthermore, the present invention relates to the production of diamines obtained from internal ketones. These diamines may be used in the method for producing twin-tail triamines according to the invention. Finally, the invention relates to a new aldehyde compound, which is an intermediate product of the method for producing twin-tail triamines of the invention.

Abstract: The present disclosure relates to an anti-PD-1 antibody pharmaceutical composition and use thereof. Specifically, the present disclosure provides a pharmaceutical composition, comprising an anti-PD-1 antibody and a buffer solution.

Abstract: The present invention relates to a method of synthesizing at least one organic acid comprising oxidizing glycolaldehyde with nitric acid in the presence of a solvent. Advantageously, it is an industrially applicable process, which prepares organic acid, notably glycolic acid and/or glyoxylic acid in a high yield based on bio-based feedstocks.

Abstract: The present disclosure provides a panel of nucleic acid molecule primers specific for HLA-specific alleles and other genetic polymorphisms, which are useful for quantitatively amplifying these markers to detect, diagnose, and monitor individuals who have or are at risk of certain disease conditions, such as autoimmune disease, proliferative disease, infectious disease, allograft rejection, or pregnancy-related pathologies.

Abstract: The present disclosure provides a panel of nucleic acid molecule primers specific for HLA-specific alleles and other genetic polymorphisms, which are useful for quantitatively amplifying these markers to detect, diagnose, and monitor individuals who have or are at risk of certain disease conditions, such as autoimmune disease, proliferative disease, infectious disease, allograft rejection, or pregnancy-related pathologies.

Abstract: A pharmaceutical composition, comprising an antibody drug conjugate in a buffer solution. The antibody drug conjugate has a structure represented by the general formula (Pc-L-Y-D). The pharmaceutical composition further comprises sugar and a surfactant.

Abstract: The present invention provides a PD-L1 antibody pharmaceutical composition and use thereof. In particular, the present invention provides a pharmaceutical composition comprising the PD-L1 antibody or an antigen-binding fragment thereof in a succinate buffer. In addition, the pharmaceutical composition may also contain a sugar and a nonionic surfactant.

Abstract: A quasi-macroscopic cold field emission electron gun and a manufacturing method thereof are provided, which includes a filament device and an electron gun base, wherein the filament device includes a cold cathode filament and a conductive capillary tube, the cold cathode filament passes through one end of the conductive capillary tube and is crimped through a pressing groove device, the other end of the conductive capillary tube is connected to the electron gun base, and the end of the cold cathode filament is the electron emission end. Through the coaxial nesting and pressing deformation of quasi-macroscopic carbon fiber and metal tube and using of the non welding electrical connection method, this technology avoids the problem that it is not easy to form a reliable electrical connection during the welding process due to the poor wettability between carbon fiber and metal.

Abstract: Provided are a pharmaceutical composition containing an anti-IL-4R antibody and the use thereof. The pharmaceutical composition contains an anti-IL-4R antibody or an antigen-binding fragment thereof in a histidine-acetic acid buffer agent, a viscosity modifier, a surfactant, and a stabilizer.

Abstract: A pharmaceutical composition containing an SOST antibody or an antigen-binding fragment thereof in an acetic acid-sodium acetate buffer solution is described. In addition, the pharmaceutical composition can also contain sugar, a nonionic surfactant or other excipients. After being stored for several months, the pharmaceutical composition exhibits good antibody stability.

Abstract: Provided is a method for preparing glycolic acid which comprises oxidizing glycolaldehyde with molecular oxygen in the presence of a solvent and a supported catalyst. Said supported catalyst comprises (i) a noble metal selected from the group consisting of Pt, Pd, Ru and Rh, (ii) Bi and (iii) a support. Advantageously, the supported metallic catalyst is more active than the catalysts used in prior art. Furthermore, the catalyst is more stable at oxygen rich conditions.

Abstract: The present invention relates to a method of synthesizing at least one organic acid comprising oxidizing glycolaldehyde with nitric acid in the presence of a solvent. Advantageously, it is an industrially applicable process, which prepares organic acid, notably glycolic acid and/or glyoxylic acid in a high yield based on bio-based feedstocks.

Abstract: The present disclosure provides a panel of nucleic acid molecule primers specific for HLA-specific alleles and other genetic polymorphisms, which are useful for quantitatively amplifying these markers to detect, diagnose, and monitor individuals who have or are at risk of certain disease conditions, such as autoimmune disease, proliferative disease, infectious disease, allograft rejection, or pregnancy-related pathologies.

Abstract: Provided are methods for prophylaxis and/or therapy for Phelan-McDermid Syndrome (PMS) and autism spectrum disorder (ASD). The methods involve administering a histone methyltransferase (HMT) inhibitor, a histone deacetylase (HDAC) inhibitor, or a combination thereof, such that one or more symptoms of the PMS and/or the AMD are reduced.

Abstract: The present disclosure provides a panel of nucleic acid molecule primers specific for HLA-specific alleles and other genetic polymorphisms, which are useful for quantitatively amplifying these markers to detect, diagnose, and monitor individuals who have or are at risk of certain disease conditions, such as autoimmune disease, proliferative disease, infectious disease, allograft rejection, or pregnancy-related pathologies.

Abstract: The present invention concerns a process for forming a primary or a secondary amine via amination reaction comprising: reacting an alcohol with an amine in the presence of a zeolite comprising a transition metal chosen in the group consisting of Group 8 to 12 elements of the Periodic Table and any combination thereof.